{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-051013","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2026-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.463850+00:00","generated_at":"2026-05-15T00:18:23.690816+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"iSpecimen effectuates 1-for-40 reverse stock split to regain Nasdaq compliance","bullets":["Reverse stock split effective 4:30 p.m. ET on April 27, 2026; trading on split-adjusted basis began April 28.","Shares outstanding reduced from 52,639,796 to approximately 1,316,032; no fractional shares issued (rounded up).","Board also ratified prior 1:20 reverse split (Sept 2024) via Certificate of Validation under Delaware law.","CUSIP changed to 45032V306; symbol remains ISPC on Nasdaq Capital Market.","Split intended to increase per-share price to attract institutional investors and meet minimum bid listing requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051013","json":"https://secwatch.observer/filing/0001213900-26-051013.json","markdown":"https://secwatch.observer/filing/0001213900-26-051013.md","text":"https://secwatch.observer/filing/0001213900-26-051013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026051013/0001213900-26-051013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026051013/ea0288258-8k_ispecimen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:18:23.690816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d4d896e69e11aa9b0dd7f170c908190c464b112c","claim":"iSpecimen Inc.: Fifth Amended and Restated Certificate of Incorporation filed to effect 1-for-40 reverse stock split and ratify prior 1:20 reverse stock split (effective 2026-04-29).","evidence_excerpt":"On April 29, 2026, iSpecimen Inc. (the “Company”) filed a Fifth Amended and Restated Certificate of Incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware, which, among other things, effectuated a reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share, at a ratio of 1-for-40 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026051013/0001213900-26-051013-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2026-04-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}